ADARx Pharmaceuticals, Inc. (ADRX) vs AnaptysBio, Inc. (ANAB)

ADARx Pharmaceuticals, Inc. ADRX 15.59 +17.22%
AnaptysBio, Inc. ANAB 48.56 −0.43%

ADARx Pharmaceuticals, Inc. and AnaptysBio, Inc. are both Biotechnology companies. ADARx Pharmaceuticals, Inc. and AnaptysBio, Inc. are of similar size ($1.5B and $1.5B).

Metric	ADRX	ANAB	Biotechnology median
P/E	—	n/m	11.58
P/S	—	6.05	9.61
P/B	—	110.24	2.26
Price to free cash flow	—	318.73	26.41
EV/EBITDA	—	27.93	0.72
EV/Sales	—	4.82	9.43
Earnings yield	—	(1.74%)	(32.28%)
Free cash flow yield	—	0.31%	(22.27%)

Metric	ADRX	ANAB	Biotechnology median
Gross margin	—	100.00%	68.81%
Operating margin	—	17.56%	0.00%
Net margin	—	(11.53%)	0.00%
Free cash flow margin	—	1.90%	0.00%
Return on equity	—	(114.55%)	(50.30%)
Return on assets	—	(7.13%)	(45.47%)
Return on invested capital	—	0.00%	0.00%

Metric	ADRX	ANAB	Biotechnology median
Revenue growth (TTM)	—	107.73%	6.78%
EPS growth (last fiscal year)	—	91.02%	29.88%
Revenue growth, 5-year CAGR	—	25.62%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ADRX	ANAB	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	7.58	4.74
Net debt to EBITDA	—	(6.84)	1.01

Metric	ADRX	ANAB	Biotechnology median
Dividend yield	—	—	0.39%
Payout ratio	—	—	—

Metric	ADRX	ANAB	Biotechnology median
Market cap	1.47b	1.46b	168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack